167 related articles for article (PubMed ID: 25587935)
21. In vivo assessment of oral administration of probucol nanoparticles in rats.
Shudo J; Pongpeerapat A; Wanawongthai C; Moribe K; Yamamoto K
Biol Pharm Bull; 2008 Feb; 31(2):321-5. PubMed ID: 18239296
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics and relative bioavailability of probucol inclusion complex capsule in healthy dogs].
Zhang Z; Chen BL; Wang K; Huang YL; Fang SQ; Gu DL; Fang L; Han SJ
Yao Xue Xue Bao; 2002 Mar; 37(3):210-3. PubMed ID: 12579765
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state.
Nielsen FS; Petersen KB; Müllertz A
Eur J Pharm Biopharm; 2008 Jun; 69(2):553-62. PubMed ID: 18294829
[TBL] [Abstract][Full Text] [Related]
24. Enhanced association of probucol with chylomicron by pharmaceutical excipients: an in vitro study.
Kim H; Seong I; Ro J; Hwang SH; Yun G; Lee J
Drug Dev Ind Pharm; 2015; 41(7):1073-9. PubMed ID: 24934664
[TBL] [Abstract][Full Text] [Related]
25. Porous starch based self-assembled nano-delivery system improves the oral absorption of lipophilic drug.
Zhang Z; Huang J; Jiang S; Liu Z; Gu W; Yu H; Li Y
Int J Pharm; 2013 Feb; 444(1-2):162-8. PubMed ID: 23340325
[TBL] [Abstract][Full Text] [Related]
26. PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression.
Qi R; Gao Y; Tang Y; He RR; Liu TL; He Y; Sun S; Li BY; Li YB; Liu G
AAPS J; 2009 Sep; 11(3):395-405. PubMed ID: 19479387
[TBL] [Abstract][Full Text] [Related]
27. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
28. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
Tran TH; Guo Y; Song D; Bruno RS; Lu X
J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737
[TBL] [Abstract][Full Text] [Related]
29. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
30. Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system.
Ke W; Zhao Y; Huang R; Jiang C; Pei Y
J Pharm Sci; 2008 Jun; 97(6):2208-16. PubMed ID: 17879294
[TBL] [Abstract][Full Text] [Related]
31. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
32. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.
Diaz C; Guzmán J; Jiménez VA; Alderete JB
Pharm Dev Technol; 2018 Sep; 23(7):689-696. PubMed ID: 28368674
[TBL] [Abstract][Full Text] [Related]
33. Dual-functionalized PAMAM dendrimers with improved P-glycoprotein inhibition and tight junction modulating effect.
Liu Y; Chiu GN
Biomacromolecules; 2013 Dec; 14(12):4226-35. PubMed ID: 24219381
[TBL] [Abstract][Full Text] [Related]
34. Effect of probucol on triton induced hyperlipidemias in CFY rats.
Krishnamurthy A; Thapar GS; Shridhar DR
Artery; 1985; 13(2):87-94. PubMed ID: 4084069
[TBL] [Abstract][Full Text] [Related]
35. The effect of probucol on atherosclerosis in streptozotocin-induced diabetic-hyperlipidemic APA hamsters in different stages of atherosclerosis.
Horiuchi K; Takatori A; Inenaga T; Ohta E; Yamanouchi J; Kawamura S; Ishii Y; Kyuwa S; Yoshikawa Y
Exp Anim; 2002 Oct; 51(5):457-64. PubMed ID: 12451706
[TBL] [Abstract][Full Text] [Related]
36. Morphology and surface States of colloidal probucol nanoparticles evaluated by atomic force microscopy.
Moribe K; Wanawongthai C; Shudo J; Higashi K; Yamamoto K
Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):878-80. PubMed ID: 18520102
[TBL] [Abstract][Full Text] [Related]
37. Effects of dietary fat levels on the absorption and tissue accumulation of probucol in the rat.
Yamamoto K; Fukuda N; Shiroi S; Shiotsuki Y; Nagata Y; Tani T; Sakai T
Arzneimittelforschung; 1994 Sep; 44(9):1059-62. PubMed ID: 7986244
[TBL] [Abstract][Full Text] [Related]
38. Enhanced bioavailability of probucol following the administration of solid dispersion systems of probucol-polyvinylpyrrolidone in rabbits.
Kubo Y; Terashima Y; Yagi N; Nochi H; Tamoto K; Sekikawa H
Biol Pharm Bull; 2009 Nov; 32(11):1880-4. PubMed ID: 19881302
[TBL] [Abstract][Full Text] [Related]
39. Oral mucus-penetrating PEGylated liposomes to improve drug absorption: Differences in the interaction mechanisms of a mucoadhesive liposome.
Yamazoe E; Fang JY; Tahara K
Int J Pharm; 2021 Jan; 593():120148. PubMed ID: 33290871
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
